Companies /Healthcare

Simulations Plus Inc

NASDAQ: SLP Health Information Services
$18.39
▼ $0.03 (−0.16%) today
Markets closed · 10:12am ET
Today · % change

Fundamentals

Market Cap
$371.9M
P/E Ratio
46.0
Profit Margin
9.9%
Revenue (TTM)
$82.1M
EPS (TTM)
$0.40
52-Week Range
$11 – $21
Street Target
$17.25

About Simulations Plus

Simulations Plus Inc specializes in advanced software for drug discovery and development. With a focus on artificial intelligence and machine learning, it offers tools like GastroPlus for simulating drug absorption and interactions. Its portfolio also includes DDDPlus, MembranePlus, and a suite of mechanistic models such as DILIsym and NAFLDsym. Beyond software, Simulations Plus provides consulting in pharmacokinetics and regulatory submissions, serving industries from pharmaceuticals to cosmetics. Founded in 1996 and based in Lancaster, California, it's a key player in supporting the lifecycle of drug development.

SLP Coverage